Entries by Yes International

Covalent Collective Appoints New CFO and COO

Colorado Springs, Colorado, Jan. 30, 2019 (GLOBE NEWSWIRE) — Covalent Collective, Inc. (“Covalent Collective” or the “Company”), a burgeoning network of vertically integrated cannabis businesses, announced today that the Company has added two new members to its leadership team with the hiring of Anthony Engel as Chief Financial Officer and Douglas Matthews as Chief Operations […]

NORTHSTAR ELECTRONICS, INC. (NEIK) PROVIDES AN INTERIM UPDATE AS ITS SUBSIDIARY ACHIEVES ANOTHER MILESTONE

Virginia Beach, VA.-January 10, 2019 – Northstar Electronics, Inc. (OTCQB: NEIK) is pleased to provide an update to its shareholders on a key milestone achieved by its subsidiary, Northstar Sealand Enterprises Ltd. (NSEL), on a major acquisition. As previously reported, NEIK and NSEL have been working closely with a major global Aerospace Company with the […]

Doyen Elements International Rebrands to Covalent Collective and Appoints Bill Gregorak as Chief Executive Officer

Colorado Springs, CO, Jan. 08, 2019– Doyen Elements International, Inc., a burgeoning network of vertically integrated cannabis businesses, announces its rebranding and renaming itself to Covalent Collective, Inc. (“Covalent Collective” or the “Company”). In addition, the Company announced Bill Gregorak as Chief Executive Officer, effective immediately. Prior to being named CEO, Mr. Gregorak served as […]

NORTHSTAR ELECTRONICS, INC. (NEIK) Expands in its Plans to Become an Original Equipment Manufacturer (OEM); Provides Professional Bios on Business Team

Virginia Beach, VA- August 15, 2018- Northstar Electronics, Inc. (OTCQB: NEIK) proceeds with its expansion from being an aerospace contract manufacturer to becoming an “Original Equipment Manufacturer” (OEM) with its own products.  NEIK made significant headway in the purchase of the worldwide rights to a single engine “Turbo Prop” airplane from a major overseas aerospace […]

BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) BECOMES FULLY REPORTING PER US SEC 1934 ACT RULES

Virginia Beach, VA- BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH: OTCMARKETS) announces that the US SEC regulators approved the Company’s FORM 10 registration under the 1934 Exchange Act (“Act”). As of August 1, 2018 the Company is fully transparent and filing reports within the rules/regulations required of the 1934 Act. The US SEC approval of the Company […]

Northstar Electronics, Inc.’s (NEIK) Progress Update

Vancouver, British Columbia-March 21, 2018 – Northstar Electronics, Inc. (OTCQB:NEIK) provides an updated report on its subsidiary, Northstar Sealand Enterprises Ltd. (NSEL). NSEL continues to work diligently to acquire a “Definitive Agreement” for the worldwide rights to a “Turbo Prop” single engine industrial airplane from a world leader in the aerospace industry. The primary applications […]

Predictive Technology Group, Inc.’s (PRED) Subsidiary Provides a Sponsorship at 4th Annual Perinatal Stem Cell Society Congress

Salt Lake City, UT- March 5, 2018- Predictive Biotech, Inc., a wholly owned subsidiary of Predictive Technology Group, Inc. (PRED.OTCPINK) provided a sponsorship at the 4th Annual Perinatal Stem Cell Society Congress, Salt Lake City, UT on March 1-2, 2018. In 2013, the Perinatal Stem Cell Society, Inc. a non-profit organization was founded on the […]

PREDICTIVE TECHNOLOGY GROUP, INC. (PRED) RETAINS DONOHOE ADVISORY ASSOCIATES LLC, TO ASSIST IN PREPARING TO SEEK A LISTING ON A NATIONAL SECURITIES EXCHANGE

Salt Lake City, UT- February 27, 2018- Predictive Technology Group, Inc. (OTCPINK:PRED) announces that it has engaged Donohoe Advisory Associates, LLC (“Donohoe Advisory”) in connection with its efforts to seek a listing for its common shares on a national securities exchange. Donohoe Advisory was founded by Dave Donohoe in 2004, and since that time the […]

PREDICTIVE TECHNOLOGY GROUP, INC. (PRED) ANNOUNCES COMPLETION OF GENOTYPING IN TWO CLINICAL TRIALS OF ARTGUIDE™

Salt Lake City, UT — February 20, 2018 — Predictive Technology Group, Inc. (OTC PINK: PRED) announces that Predictive Therapeutics, LLC, its wholly-owned subsidiary, completed a crucial milestone in the development and commercialization of ARTGuide™. The Company’s scientific team completed the genotyping in two clinical trials of ARTGuide™. As such, Company representatives are providing three […]